NIAID utilizes $577M to establish nine pathogen antiviral drug development centers

Through awards amounting to approximately $577 million, the National Institute of Allergy and Infectious Diseases (NIAID) is working to create nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern, working to develop innovative drugs. 

“The COVID-19 pandemic has highlighted the need for new antiviral drugs, especially those that could easily be…